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Intracellular 30-50-cyclic adenosine monophosphate (cAMP) is one of the principal second
messengers downstream of a manifold of signal transduction pathways, including the
ones triggered by G protein-coupled receptors. Not surprisingly, biochemical assays
for cAMP have been instrumental for basic research and drug discovery for decades,
providing insights into cellular physiology and guiding pharmaceutical industry. However,
despite impressive track record, the majority of conventional biochemical tools for cAMP
probing share the same fundamental shortcoming—all the measurements require sample
disruption for cAMP liberation. This common bottleneck, together with inherently low
spatial resolution of measurements (as cAMP is typically analyzed in lysates of thousands
of cells), underpin the ensuing limitations of the conventional cAMP assays: (1) genuine
kinetic measurements of cAMP levels over time in a single given sample are unfeasible;
(2) inability to obtain precise information on cAMP spatial distribution and transfer at
subcellular levels, let alone the attempts to pinpoint dynamic interactions of cAMP and
its effectors. At the same time, tremendous progress in synthetic biology over the recent
years culminated in drastic refinement of our toolbox, allowing us not only to bypass
the limitations of conventional assays, but to put intracellular cAMP life-span under tight
control—something, that seemed scarcely attainable before. In this review article we
discuss the main classes of modern genetically-encoded tools tailored for cAMP probing
and modulation in living systems. We examine the capabilities and weaknesses of these
different tools in the context of their operational characteristics and applicability to various
experimental set-ups involving living cells, providing the guidance for rational selection of
the best tools for particular needs.
Keywords: cAMP signaling, cyclic nucleotide, biosensor, genetically encoded probe, optogenetics, cell-based
assays
Introduction
The small molecule 30-50-cyclic adenosine monophosphate (cAMP) is an established second
messenger, involved in signal transduction in most living organisms. Being instrumental in
regulation of a plethora of processes both in health and pathological states, principles of cAMP
signaling have remained in the research spotlight for the best part of the last century and the interest
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to this cyclic nucleotide does not seem to fade away (Beavo
and Brunton, 2002; Lefkimmiatis and Zaccolo, 2014). To a
certain degree this is attributed to the immense pharmacological
significance of G protein-coupled receptors (GPCRs), which
have cAMP for an immediate intracellular effector and continue
to serve as drug targets for as much as one third of the
pharmaceutical compounds marketed worldwide (Filmore, 2004;
Overington et al., 2006).
As it typically happens with branches of knowledge that are
built up on empirical observations, the perceptions of cAMP-
mediated signal transmission in living systems have been (and
continue to be) shaped by the input from the experimental and
analytical tools available to research community. The truism “we
can only go as far as our instruments will allow us to” is nicely
exemplified by the changes in the paradigm of cyclic nucleotide
signaling, occurring in the last decades.
Conventional biochemical methods, such as chromatography
with tritium—prelabeled adenine pool and antibody-dependent
competition assays, that made the platform for cAMP studies till
1990-x, though robust and applicable to essentially any bodily
tissue, can measure only the unresolved bulk of cAMP levels
in pooled cellular populations, thus leaving us to guess what is
going on with cAMP molecules in any given single cell. Apart
from the limited spatial resolution, biochemical assays typically
require cAMP liberation from specimens under study, which is
usually accomplished by cell lysis (Williams, 2004; Hill et al.,
2010). This way, biochemical assays in essence provide a single
time point measurement, reflecting the total cAMP levels present
in a specimen at the time of cell disruption. Though it is possible
to deduce the overall kinetic trend of total cAMP over a time
period by preparing a set of biological replicates and lysing them at
certain intervals, the resulting kinetic curve is usually only a faint
reflection of the actual cAMP oscillations in a given biological
sample.
Experimental data on cAMP, obtained with biochemical
methods with limited temporal and spatial resolution, formed
the basis for a widely accepted model of cAMP signaling. This
model implies cAMP generation by membrane-bound adenylyl
cyclases (ACs) in response toGPCRs activation and its subsequent
free diffusion into the cytoplasm. The ensuing activation of
immediate cytoplasmic effectors of cAMP, such as protein kinase
A (PKA), convey the signal further to the level of cell nucleus,
eventually translating extracellular stimuli into transcriptional
response (Beavo and Brunton, 2002).
However, cAMP network and governing principles of its
functional and structural organization happen to be far more
complex. Indeed, the conceptualization of cAMP signaling
as of a highly compartmentalized process, occurring in
separated subcellular domains, shaped by anchoring proteins
and phosphodiesterases (PDEs), with organization of the
key players of cAMP-mediated signal relay machinery into
supramolecular complexes or “signalosomes,” has just started to
evolve (Willoughby and Cooper, 2007; Lefkimmiatis and Zaccolo,
2014). Apart from the intricate laws of spatial organization of
cAMP generation, trafficking and degradation, this burgeoning
model recognizes the multifaceted nature of signal encoding by
cAMP (strength vs. duration vs. frequency) and pays due regards
to the crosstalk between cAMP and other intracellular regulators
(Rich et al., 2014).
It wound not be an overstatement to say, that the major insights
into the complexity of cAMP signaling, served to fuel the above
conceptual framework, were gained by studies exploiting next
generation of tools for cAMP probing and modulation. Most of
these tools are genetically encoded proteins, tailored for sensing
and modulation of cAMP in living systems. These engineered
proteins provide excellent spatial resolution down to desired
subcellular domains, can respond to genuine oscillations of cAMP
levels in real time and are designed to uncover cAMP signaling
partners, and as such have enabled a paradigm-shift in cyclic
nucleotide research.
Evidently, in order to scrutinize a complex phenomenon, a
set of diverse probing tools is required. Align with this and
thanks to the intricate nature of cAMP signaling relay and never-
ceasing attempts to gain insights into the laws of the game, several
families of biosensors for cAMP have been developed (reviwed
in Willoughby and Cooper, 2008; Hill et al., 2010; Sprenger
and Nikolaev, 2013). However, besides being genetically-encoded
proteins and hence applicable to studies in living cells, themodern
biosensors do not have much in common, as they strive to probe
different aspects of cAMP signaling, are governed by distinct
biological phenomena and rely on diverse biophysical techniques.
Considering this heterogeneity and in order to make this
review more sound and cohesive, we decided to categorize the
biosensors into two major groups: tools for direct measurement
of cAMP and tools for indirect cAMP probing. As the name
implies, direct probes provide first hand cAMP measurements,
with a readout typically being generated immediately after binding
between cAMP and the sensor molecules. Additionally, the
readout intensity from direct biosensors is usually proportional
to the intensity of stimulation, which allows the direct probes
to convey valid data on actual oscillations of intracellular cAMP
levels. In contrast with direct probes, indirect biosensors typically
measure the effects of cAMP on its downstream effectors. In case
of indirect cAMP sensing, there is always at least one intermediary
between actual concentration of cAMP and the readout from the
probe. Obviously, in order to deduce genuine cAMP levels from
such an indirect readout, one has to be aware of the relations
between cAMP and its effector being probed and to account for
Abbreviations: AC, adenylyl cyclase; AKAR, A-kinase activity reporter; BLUF, blue light receptor using FAD; BRET, bioluminescence resonance energy
transfer; CaM, calmodulin; cAMP, 30-50-cyclic adenosine monophosphate; CCD, charge-coupled device; CFP, cyan fluorescent protein; cGMP, 30, 50-cyclic
guanosine monophosphate; CNBD, cyclic nucleotide-binding domain; CNGC, cyclic nucleotide-gated channel; CRE, cAMP-response element; CREB, cAMP-
response element-binding protein; Epac, exchange protein, directly activated by cAMP; FlCRhR, FRET sensor based on PKA (Fluorescein + Catalytic
unit/Rhodamine+Regulatory unit); FRET, Förster resonance energy transfer; FSK, forskolin; GFP, green fluorescent protein; GPCR,G protein-coupled receptor;
HCN, hyperpolarization-activated cyclic nucleotide-gated channels; HTS, high-throughput screening; IBMX, 3-isobutyl-1-methylxanthine; LAPD, light-
activatable phosphodiesterase; LOV, light-oxygen-voltage-sensing domain; NO, nitric oxide; PAC, photoactivatable adenylyl cyclase; PDE, phosphodiesterase;
PKA, protein kinase A; RIIb, regulatory subunit IIb of protein kinase A; Rluc, Renilla reniformis luciferase; sAC, soluble adenylyl cyclase; YFP, yellow fluorescent
protein.
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possible interference that may happen on the way of signal relay.
Though the above inherent factors limit the use of indirect sensors
for measurement of actual levels of cAMP, the very nature of
these sensors makes them excellent tools for studies of cAMP
downstream effects.
In the following sections, we consider the modern cAMP
biosensors with respect to the above categorization and discuss
the principal groups of probes in more detail, highlighting
their strengths and limitations. After that, we provide some
guiding landmarks that would be of some assistance to the
reader facing an uneasy task of selection of the most appropriate
tool for cAMP probing for a particular experiment involving
living cells. We finish the article with a short prospect on
selected genetically-encoded tools for cAMPmodulation in living
systems. Combinatorial use of these cutting-edge instruments
with biosensors for cAMP creates the most powerful research
platform, which opens new avenues for fruitful studies of the life
cycle and signaling properties of this cyclic nucleotide.
Tools for Direct cAMP Measurement in
Living Cells
Irrespectively of the nature of readout produced upon cAMP
binding (e.g., fluorescence or luminescence), direct sensors
detect cAMP molecules by means of native or modified cyclic
nucleotide-binding domains (CNBDs) invariably present in its
structure. All the CNBD exploited in modern sensors have been
adopted from cAMP-binding domains of the three principal
downstream cAMP effectors: PKA, exchange proteins activated
by cAMP (Epac) or cyclic nucleotide-gated channel (CNGC;
Kamenetsky et al., 2006; Willoughby and Cooper, 2007).
A prototypical direct biosensor for cAMP is a conformationally
flexible multidomain protein, which undergoes a structural
change once cAMP molecule lands in the pocket of the CNBD,
followed by a change in the signaling intensity of the sensor,
which is used to deduce the concentrations of cAMP the sensor is
exposed to. Below we review the principal classes of direct cAMP
sensors based on the type of signal they generate in response to
cAMP (Figure 1).
Förster Resonance Energy Transfer
(FRET)-Based Sensors
Introduced in the early 1990s, biosensors based on FRET
phenomenon have been instrumental in shaping of our
understanding of the actual principles governing cAMP
generation, flow, crosstalk and decay in defined compartments
of living cells (Willoughby and Cooper, 2007; Lefkimmiatis and
Zaccolo, 2014). Not surprisingly, FRET sensors remain the most
popular and widely used tool for cAMP studies in living cells,
with several dozens of distinct probes generated over the last
three decades. For this reason, we will not discuss all the available
cAMP FRET-based sensors in very detail—the reader is addressed
to several comprehensive review papers instead (Willoughby and
Cooper, 2008; Sprenger andNikolaev, 2013; Gorshkov andZhang,
2014). Instead, we shall try to highlight the basic principles of the
method, advantages it offers and limitations one should keep in
mind once planning an experiment with FRET-derived readout.
Förster resonance energy transfer refers to a mechanism of
non-radiative energy transfer between a pair of light-sensitive
molecules (fluorophores), a donor and an acceptor, that have
partially overlapping spectral characteristics. For the transfer
of energy, fluorophores making a FRET pair should be in
close proximity (typically, within several nm from each other)
and have a favorable relative orientation. As the efficiency of
donor—to—acceptor energy flow is inversely proportional to the
six power of the distance between fluorophores of any given FRET
pair, the method is exceptionally sensitive to tiny alterations in
FRET pair collocation (Forster, 1946; Correa and Schultz, 2009).
This way, FRET intensity and its alterations provide an excellent
reflection of a distance change between two fluorophores.
Förster resonance energy transfer intensity is typically
measured by calculating a ratio of emission intensities of donor
and acceptor molecules registered upon donor fluorophore
excitation with light of the appropriate wavelength. Another way
to estimate the degree of FRET is to photobleach an acceptor
fluorophore and to track the rise in donor emission intensity.
FRET efficiency estimates obtained with any of the above
approaches are ratiometric in essence and are usually corrected
for possible bleed-through of donor emission into the acceptor
channel (Correa and Schultz, 2009).
In general, all FRET biosensors are designed to operate in
the similar fashion. A prototypical FRET sensor represents a
complex molecular structure with three principle domains: a
sensor domain, that is in charge of binding to a molecule or
compound of interest to be measured, and two fluorophore
domains making a FRET pair. A binding of a target molecule
to a sensor domain triggers a chain of conformational changes
in a biosensor tertiary structure, which should lead to a change
of distance between donor and acceptor fluorophores and result
in alteration of FRET efficiency. Though multitude of variations
in sensor design are possible, the above operational principle
remains valid for all FRET biosensors, with the ones developed
for cAMP not being an exception.
Since the number ofmolecules forming a sensor is an important
factor that has several significant implications (reviewed below),
we are considering all FRET cAMP indicators in the context of
two big “families”: a family of multimolecular sensors, members
of which are build up of at least two different molecular units
carrying separate domains, and a family of unimolecular sensors
having a sensor and a FRET pair within a singlemolecule. Units of
a multimolecular sensor can either dimerise or dissociate, and any
of these events should be accompanied by a measurable change in
FRET intensity.
Multimolecular FRET Sensors for cAMP
In essence, all of the multimolecular FRET sensors for cAMP
generated so far represent different genetically engineered
modifications of PKA, one of the principal downstream effectors
of cAMP. PKA holoenzyme is a heterotetrameric complex
conformed by two subunits: the catalytic (C) and the regulatory
(R) subunit, arranged in a C2:R2 ratio. Binding of cAMP to the
R subunits results in conformational change and the dissociation
of the two, now active, C subunits from a tandem of R units, that
remain attached to each other.
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FIGURE 1 | (Continued)
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FIGURE 1 | Main classes of direct biosensors for cAMP. A prototypical structure and mechanism of action of unimolecular and multimolecular FRET sensors (A
and B respectively), BRET sensors (C), sensors, based on luminescent enzymes (D), and probes operating as conformation-sensitive fluorophores (E), are depicted.
All the listed sensors directly bind cAMP molecules and react to binding events with conformational changes that affect their signaling properties—FRET or BRET
efficiency (purple arrow), intensity of light production or fluorescence (winding arrows). For more details, please, refer to corresponding sections of the text.
Abbreviations: C, PKA catalytic subunit; CFP, cyan fluorescent protein; GRN, green fluorophore; Luc, luciferase; LucN/C, fragments, forming luciferase holoenzyme;
R, PKA regulatory subunit; RED, red fluorophore; RP, regulatory protein; YFP, yellow fluorescent protein.
More than 25 years ago, the group of Tsien reported on the
first successful use of FRET sensor for cAMP measurement
in living cells (Adams et al., 1991). This sensor, named
FlCRhR, represented the chemically modified PKA, which
had its C subunits labeled with fluorescein fluorophore
and R subunits tagged with rhodamine (hence the name:
Fluorescein + Catalytic unit/Rhodamine + Regulatory unit) in
FRET distance in the inactive holoenzyme. Binding to cAMP
evoked PKA holoenzyme dissociation with measurable drop
in FRET efficiency, as fluorescein and rhodamine were not
in the immediate vicinity any longer for successful FRET to
occur.
FlCRhR turned out to be a groundbreaking tool, as it allowed
for real-time measurement of intracellular cAMP in physiological
concentrations and provided a wealth of information on spatial
cAMP dynamics. However, this sensor was produced ex vivo by
means of chemical labeling and hence had to be introduced into
cytoplasm of single cells via microinjection that was obviously
technically demanding and significantly limited the processivity
of the method.
Such limitation was overcome a few years later with
development of a set of genetically-encoded FlCRhR analogs,
that could be expressed in living cells by means of transfection or
viral transduction (Zaccolo et al., 2000). Additionally, PKA-based
FRET sensors evolved improved characteristics in successive
generations, including broader dynamic range and higher
resistance to photobleaching (Lissandron et al., 2005).
Nonetheless, despite all the modifications, PKA-based sensors
still bear several common shortcomings, and most of these are
actually related to the very nature of PKA and its mode of
operation. Firstly, despite being labeled with a pair of FRET
fluorophores, PKA holoenzyme—based sensors preserve catalytic
activity. This way, a rise in cAMP triggers the complex chain
of signaling events, involving effectors downstream of PKA and
altering transcriptional activity of cAMP-dependent genes (Beavo
and Brunton, 2002; Cooper, 2003; see also the section of this
review on Reporter Gene-Based Systems). These effects form
a potential basis for short and long-term interference, which
in some cases might not be immediately obvious and quite
difficult to correct for, e.g., in prolonged studies with either
chronic or multiple exposure to certain agents. Secondly, as
PKA holoenzyme naturally dissociates upon cAMP binding, one
should expect the reassembled holoenzyme to have incorporated
endogenous non-fluorescent C subunits inevitably present in
cell cytoplasm. Obviously, this might lead to loss of overall
FRET efficiency with each dissociation–reassociation cycle, as
the fraction of reassembled PKA holoenzymes will not carry
FRET pairs any more. Besides, it should be recognized, that more
complex structural dynamics of PKA-based probes, involving
integration of a tetrad of subunits, might negatively affect
temporal resolution of these sensors, potentially making them
inferior to unimolecular probes in this regard (Rich et al., 2014).
In order to alleviate unwanted interference from endogenous
PKA subunits, PKA-based sensors are to be heavily expressed.
However, high levels of sensor expression combined with its
naturally high affinity to cAMP might lead to significant cAMP
buffering, thus distorting genuine patterns of cAMP spatio-
temporal dynamics (Rich and Karpen, 2002). Another related
issue is the necessity of equal expression levels of both PKA
subunits, which are usually encoded by separate vectors and
hence require co-transfection (Zaccolo et al., 2000). Lastly, some
experimental evidence suggest that PKA might be activated by
30, 50-cyclic guanosine monophosphate (cGMP), which opens
new avenues for interference and might lead to decrease in assay
specificity (Forte et al., 1992).
The multimolecular structure and cooperative nature of
action of PKA-based cAMP probes underpin significant part of
the above limitations, which in essence are inherent to most
multimolecular FRET sensors. Conversely, unimolecular FRET
sensors, developed in the ensuing years, allowed to bypass some
of the old problems and made a valuable addition to the cAMP
toolbox (discussed below).
Unimolecular FRET Sensors for cAMP
The majority of unimolecular FRET sensors for cAMP
currently available are based on genetically modified Epac
proteins—exchange factors, directly activated by cAMP. Epac1
and Epac2 are closely related multidomain proteins that basically
act as guanine nucleotide-exchange factors for the small GTPases
Rap1 and Rap2. Binding of a single cAMP molecule to the
CNBD of Epac1/2 triggers a conformational change with ensuing
exposure of initially shielded catalytic domain, allowing it to
bind and activate Rap1/2. In such fashion, Epac proteins, apart
from PKA and CNGCs, are recognized as another immediate
downstream effectors of cAMP (Bos, 2006).
The first reports on generation of Epac-based FRET sensors and
their successful use for cAMP measurements in living cells trace
back to 2004, when three independent research teams published
their data (DiPilato et al., 2004; Nikolaev et al., 2004; Ponsioen
et al., 2004). Since then the engineering activity in the field of
unimolecular biosensors does not seem to cease and a host of
improved sensor modifications have been developed, showing
better signal-to-noise ration, enhanced temporal resolution and
decreased sensitivity to light (Van der Krogt et al., 2008; Gorshkov
and Zhang, 2014; Klarenbeek et al., 2015). All Epac-based sensors
have a unimolecular structure and follow the similar design: a
native ormodified CNBD fromEpac protein is typically decorated
by two fluorophores involved in FRET. Binding of cAMP to the
CNBD evokes a change in the sensor’s tertiary conformation,
which is accompanied by alteration of FRET intensity.
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Unimolecular FRET sensors provide several advantages over
multimolecular cAMP probes. As all the functional domains are
localized within a single molecule, the kinetics of conformational
changes is more favorable—hence, unimolecular sensors have
a faster response to cAMP (= higher temporal resolution) in
comparison to more bulky multimolecular PKA-based sensors
that require binding of four cAMP molecules (Nikolaev et al.,
2004). Again, with unimolecular sensors only a single vector
is needed for transfection and the unbalanced expression of
different subunits that might be observed with multimolecular
PKA sensors is no longer an issue. A handful of catalytically dead
Epac sensors have been developed as well, thus eliminating the
possible interference from Epac downstream targets (Nikolaev
et al., 2004; Ponsioen et al., 2004; Klarenbeek et al., 2011).
Endogenous Epac molecules have a lower sensitivity to cAMP
than PKA holoenzyme (Bos, 2006). In line with this, PKA-based
sensors are readily activated by nanomolar levels of cAMP, but
affinities of Epac probes typically lie within lowmicromolar range
(Bacskai et al., 1993; Ponsioen et al., 2004). Yet, higher sensitivity
of PKA sensors comes with the price of early saturation and a
narrowed dynamic range. Considering this, Epac-based probes
appear advantageous, as they allow for measurements of cAMP
at higher, but more physiologically relevant levels.
Apart from Epac probes, a few other unimolecular FRET
sensors for cAMP have been engineered. One example is PKA-
camps sensor, that represents a truncated regulatory IIb-subunit
(RIIb) of PKA flanked by yellow and cyan fluorescent proteins
(YFP and CFP respectively) making a FRET pair. PKA-camps
has no catalytic activity and operates in the same fashion
as Epac sensors: binding of one molecule of cAMP to RIIb
triggers a conformational rearrangement, manifested by FRET
efficiency changes (Nikolaev et al., 2004). HCN2-camps is another
unimolecular FRET probe for cAMP, which is based on a
single cAMP binding domain of murine hyperpolarization-
activated CNGC sandwiched between YFP and CFP. HCN2-
camps has a lower sensitivity to cAMP and extended dynamic
range (1–100 mM). Therefore, HCN2-camps is not prone to early
saturation and thus tailored to cell types with elevated basal
levels and amplitude oscillations of cAMP, e.g., cardiomyocytes
(Nikolaev et al., 2006; see also the section of this review on
CNGCs).
Though most of the FRET biosensors are designed for direct
binding (and hence sensing) of cAMP, there are several related
genetically-encoded FRET probes, that can be used for indirect
measurement of cAMP levels, using PKA activity as readout. The
so-called AKAR sensors (A-Kinase Activity Reporters) operate in
the very similar fashion to unimolecular FRET sensors for cAMP
and hence are briefly discussed herein. AKARs have a prototypical
tetra-domain structure comprised of a PKA-specific substrate
and a phosphoamino acid-binding unit sandwiched between two
fluorophores making a FRET pair. Upon cAMP binding to PKA
holoenzyme the released and activated C subunits phosphorylate
the substrate sequence of AKARs, thus making it an appealing
bait for the neighboring phosphoamino binding domain. This
results in a change of sensor tertiary conformation, leading to
alteration in FRET efficiency (Zhang et al., 2001; Allen and
Zhang, 2006; Erard et al., 2013). It should be noted that AKARs
have all the functional domains residing in a single protein,
and as such enjoy all of the benefits of modern unimolecular
sensors, including possibility of targeting to defined intracellular
compartments (Allen and Zhang, 2006; Depry et al., 2011). On
one hand, the indirect nature of the readout provided by AKARs
and the propensity of PKA to amplify the incoming signal from
cAMP, alongside with difficulties of calibration, render AKARs
suboptimal tools for cAMP measurement, while on the other
hand, when used for direct indication, i.e., for PKA activity studies,
AKARs can show excellent performance.
Both multi- and unimolecular FRET sensors share a principle
advantage—targetability to discrete subcellular compartments.
By introducing mutations to native domains (e.g., alteration
or removal of Disheveled/Egl/10-Pleckstrin domain of Epac,
responsible for membrane anchoring) or fusing Epac proteins
or PKA subunits with appropriate targeting signals, e.g., nuclear
or mitochondrial localization signals, or membrane anchoring
motifs (farnesylation, palmitoylation, or polybasic sequences),
several sensors were successfully routed to desired compartments,
including plasma membrane, cytoplasm, mitochondria, and
nucleus (DiPilato et al., 2004; Ponsioen et al., 2004; Dyachok et al.,
2006; Terrin et al., 2006; Sample et al., 2012). This very ability
to provide outstanding spatial resolution, unattainable with other
biosensors, combinedwith quick response and reversible nature of
conformational changes induced upon cAMP binding, underpins
the true power of FRET sensors as tools for cAMP measurement
in living cells. Currently FRET sensors remain the tools of choice
once cAMP real-time dynamics in defined subcellular regions
comes to question.
All modern FRET sensors for cAMP are genetically-encoded
proteins and hence can be used not only in cell cultures, but
in laboratory animals as well, providing insights into cAMP
life-cycle in non-perturbed microenvironment (Nikolaev et al.,
2006; Calebiro et al., 2009; Jacobs et al., 2010; Sprenger et al.,
2015). The ratiometric nature of FRET brings additional benefits,
allowing to correct for cell-to-cell variation in sensor expression
levels and to minimize the effects of auto-fluorescence and light
scattering. Besides, FRET biosensors do not require additional
expensive substrates for signal generation, as it is the case for all
bioluminescence-based methods (see below).
Nevertheless, just like as all the other methods in life sciences,
FRET sensors for cAMP have certain limitations. Firstly, FRET
methodology is heavily dependent on microscopy and image
analysis. Though a basic microscopy set-up suitable for FRET
should be affordable formost labs (Börner et al., 2011), conversion
of images into figures (i.e., from pixel intensity to cAMP levels)
requires manual image processing, which is not only laborious,
but might inadvertently lead to introduction of bias, e.g., while
defining regions of interest to be analyzed (Rich et al., 2014).
However, computer-assisted tools for automated image processing
and emerging methods of signal acquisition and interpretation
such as hyperspectral imaging already offering new solutions to
old problems and hold promise for the future (Francis et al., 2012;
Leavesley et al., 2013).
Another facet of complicated image processing is a relatively
poor suitability of FRET-based biosensors for high-throughput
applications. Though it is possible to run FRET assays inmultiwell
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plate format on a fluorescence platereader and some attempts to
increase throughput have been made (Allen and Zhang, 2006),
currently other tools (see the section of this review on luciferase-
based biosensors) appear to be preferential when high processivity
or compound screen are desired.
When dealingwith fluorescent proteins, it is prudent to account
for possible effects of pH, temperature and other environmental
factors, as these variables are known to influence performance
of fluorophores and hence FRET efficiency (Correa and Schultz,
2009; Betolngar et al., 2015). This issue might become more
pronounced, when targeted FRET biosensors are used, as sensor
exposure to certain environmental factors might be different
in distinct subcellular domains (e.g., pH and ROS levels in
mitochondria; Putnam, 2012; Rich et al., 2014). Resistance to
photobleaching is another variable affecting ultimate performance
of a FRET pair to keep in mind once choosing the right
sensor for experiment. At the same time, there has been a
significant progress in the field, with recent generations of FRET
sensors for cAMP appear to be more resistant to pH and
photobleaching (Klarenbeek et al., 2011, 2015; Salonikidis et al.,
2011).
It should be mentioned, that the conversion of FRET signal
into absolute values of cAMP is not a trivial task. The most
frequently used approach relies on calibration of a purified sensor
against different concentrations of cAMP in vitro—however, this
set-up is obviously unable to mimic physiologic conditions a
sensor is exposed to inside living cells (Börner et al., 2011). An
alternative and more physiological calibration method that has
been recently introduced involves perfusion of sensor-carrying
cells with different concentrations of cAMP via patch-clamp
pipette, so the sensor remains and responds to cAMP in the
native milieu (Koschinski and Zaccolo, 2015). Still, this protocol
is obviously quite technically demanding and requires ample
expertise with patch-clamp.
Last, but not least, FRET biosensors, like any other genetically
encoded proteins, tend to have relatively high, non-physiological
levels of expression, which may lead to excessive binding and
thus buffering of cAMP. Buffering ability of a sensor becomes
of more concern once targeted proteins are used, resulting in
high local concentrations of cAMP-avid sensor molecules within
certain subcellular compartments. The buffering phenomenon
might distort natural patterns of cAMP synthesis, transport and
breakdown, limiting a sensors ability to convey actual information
on cAMP changes in living cells (Willoughby and Cooper, 2008).
Noteworthy, cAMP buffering is not a unique limitation of FRET
probes—this problem is inherent to all genetically encoded cAMP
sensors that function as cAMP binders.
Bioluminescence Resonance Energy Transfer
(BRET)-Based Sensors
In essence, BRET and FRET are closely related phenomena, that
are governed by the same physical laws and rely on the same
principle of non-radiative energy transfer between a couple of
closely opposed molecules (Forster, 1946). The only difference
between FRET and BRET is in the type of a donor molecule: in
case of FRET a fluorophore acts as a donor of energy, but in BRET
a bioluminescent protein is used instead.
Enzymatically active variants of Renilla reniformis luciferase
(Rluc) are typically used for donor molecules in the majority of
BRET pairs. Oxidation of the substrate (coelenterazine) by Rluc
results in the release of energy, which is either emitted as photons
of light or transferred to an acceptor fluorophore, provided the
latter is in the close proximity. In this fashion, no external source
of light to excite donor molecule is required, which underpins
most of the advantages of the BRET approach, including absence
of photobleaching, phototoxicity and autofluorescence (Bacart
et al., 2008). Besides, BRET is applicable to studies of light-
dependent and light-sensitive processes, e.g., visual perception
and photosynthesis (Saito et al., 2012). Lastly, such experimental
tools as optogenetics (discussed below) and caged compounds
liberated upon exposure to light can be combined with BRETwith
minimal chances of interference, which is not the case with FRET,
requiring strong external illumination (Ellis-Davies, 2007; Fenno
et al., 2011).
Only a handful of genetically encoded sensors suitable for live
cell measurements of cAMP based on BRET phenomenon have
been developed so far. All of these essentially exploit the same
design principle and operate in similar fashion as the multi-
and unimolecular FRET cAMP sensors reviewed earlier. The
only available multimolecular BRET sensor for cAMP probing
to our knowledge is based on PKA holoenzyme, which has
its regulatory and catalytically subunits decorated with Rluc
and a green fluorescent protein (GFP) variant, respectively.
Hence, PKA holoenzyme dissociation upon cAMP binding is
paralleled by pronounced drop in BRET, captured as a ratio of the
emission values (Prinz et al., 2006). Unimolecular BRET cAMP
indicators typically feature a cAMP binding motif of either Epac
or PKA regulatory subunit sandwiched between a luciferase and a
fluorescent protein, making a BRET pair (Jiang et al., 2007; Barak
et al., 2008; Saito et al., 2012).
A slightly different design principle was exploited by Saito et al.
(2012), who inserted Epac1-derived cAMP binding motif into the
non-structural loop of a chimera YFP (Venus)-Rluc. The resulting
sensor, named Nano-lantern (cAMP1.6), has the Rluc separated
by the Epac1 motive into two complementary parts, rendering
enzyme inactive as far as the cAMP-binding domain remains
vacant. cAMP binding to the sensor evokes a conformational
change and the restoration of Rluc structure and enzymatic
activity, leading to BRET with the chimeric Venus protein. In
such fashion, Nano-lantern (cAMP1.6) combines BRET and
complementation of split luciferase principles, providing lower
background signal and increased sensitivity for the assay.
Similar to FRET probes, BRET sensors are applicable to
transgenic animals and can be targeted to desired subcellular
compartments by means of introduction of appropriate
localization signals (Barak et al., 2008; Saito et al., 2012). However,
the intensity of BRET signal is still much weaker than emission
from FRET indicators, which presently hinders efficient use of
BRET sensors for single cell measurements or for tracing cAMP
fluctuations in subcellular domains (Willoughby and Cooper,
2008; Saito et al., 2012).
In general, BRET sensors have a favorable dynamics of spatial
rearrangements (several seconds) in response to changes in cAMP
levels. The fast and reversible nature of BRET response makes
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the indicators of this class well-suited for real-time measurement
of cAMP in pools of living cells (Jiang et al., 2007). Another
principal advantage of BRET sensors is their applicability for high-
throughput screening (HTS). As generation of BRET signal is not
dependent on external source of light, the signal capture becomes
much easier. BRET sensors do not need dedicated microscopy
set-up, required for FRET sensors, and the assays can be easily
carried out in multiwell plates on a platereader equipped with the
appropriate filter set. Simplified readout expressed as a ratio of two
emissions obviates the tedious image processing typical of FRET
and adds to the processivity of the assay (Boute et al., 2002; Jiang
et al., 2007; Bacart et al., 2008).
At the same time, apart from the highlighted specialties, BRET
and FRET-based cAMP indicators are largely similar. Hence, most
of the strong points and shortcomings inherent to unimolecular
and multimolecular FRET sensors reviewed in the previous
section remain valid for BRET sensors of similar design as well.
Direct Sensors for cAMP, Based on Luminescent
Enzymes
Though luminescent enzymes have an impressive record as
reporters in functional studies of gene expression, their use as
biosensors for direct probing of various intracellular molecules
has started less than a decade ago (Hill et al., 2001; Jiang et al.,
2008; Binkowski et al., 2009).
At large, all sensors of this class are genetically encoded proteins
of similar operational structure, which are based on a variant of
luciferase fused with functional domains responsible for sensing
of desired analytes. Interaction of a sensing domain with its ligand
typically triggers conformational rearrangement of the luciferase,
altering its enzymatic activity and changing the output of light.
Bioluminescent sensors only require appropriate substrate (e.g.,
luciferin or coelenterazine) and molecular oxygen for generation
of photons and hence are not dependent on exogenous light
source. As most of biological samples do not produce any light per
se, this feature of luminescent probes not only endows them with
excellent sensitivity and signal-to-noise ratio, but also helps to
avoid amultitude of problems inherent to fluorescent proteins and
fluorophore-based sensors (discussed in the previous section).
A few dedicated biosensors for cAMP based on mutated
variants of luminescent enzymes have been engineered so far.
An elegant approach is the dual-wavelength cAMP indicator
engineered by Takeuchi et al. (2010). This unimolecular
genetically-encoded sensor is based on N-terminal fragments of
two different click beetle luciferases (ElucN and CBRN) and one
C-terminal fragment (McLuc1)which could dimerizewith any the
above N-terminal fragments, forming two distinct luminescent
enzymes with well-separated emission peaks (613 nm for ElucN
and 538 nm for CBRN).
The cAMP binding domain of PKA RIIb, that is linked to
the luciferase fragments by peptide bridges, serves for cAMP
sensing unit. In the absence of cAMP, McLuc1 and ElucN form a
functional enzyme that generates red light. Upon cAMP binding
to PKARIIb the sensor undergoes conformational rearrangement,
leading to separation of the red light-producing luciferase and
migration of McLuc1 toward CBRN, culminating in restoration
of CBRN holoenzyme and green light production. This way, the
sensor was originally designed to provide ratiometric readout of
cAMP levels expressed as a shift of red to green light emission
intensities.
Sadly, the resulting sensor refused to behave strictly according
to the initial design assumptions: although cAMP binding did
result in generation of green light, this was not paralleled by a
drop in red light emission. This irresponsiveness of the red light
luciferase to probe occupancy with cAMP narrows the signal-
to-noise ratio of the sensor and deprives it of all the benefits
that genuine ratiometric readout provides, e.g., insensitivity to
differences in sensor expression levels or variations in substrate
availability. Nevertheless, apart from this issue, the indicator has
a good cAMP sensitivity range (1.0  10 7 to 1.0  10 4 M)
and is easy to use for semi-quantitative cAMP probing in
cell populations, including high-throughput setting. Though the
relatively weak light intensity precludes studies of cAMP in
subcellular compartments, the sensor can produce fair kinetic data
on total cAMP oscillations in cellular pools over extended periods
of time.
Another example of cAMP luminescent indicators is a
dyad of similar sensors (pGloSensor-20F and its successor
with improved characteristics pGloSensor-22F), based on a on
circularly permutated variant of a firefly luciferase fused with
cAMP-binding domain B of PKA RIIbB, which were developed
byWood and colleagues (Fan et al., 2008; Binkowski et al., 2011a).
In these probes, RIIbB domain acts as an allosteric regulator of
the adjoined luciferase—“landing” of a single cAMP molecule
in the RIIbB pocket allows the silent luciferase to regain the
enzymatically active conformation, which in the presence of the
substrate (luciferin) immediately leads to light production. With a
detection limit in low nanomolar range and outstanding dynamic
window (0.003—100 mM for the improved 22F version of the
sensor), GloSensor proteins are some of the most sensitive cAMP
sensors presently available. These features, combined with the
benefits of using the light emission as a readout (very low levels
of non-specific signal) and broad linearity of response to cAMP,
endow the probes with unsurpassed signal-to-noise ratio of up
to 800-fold (Binkowski et al., 2011a). On top of it, fast dynamics
and reversibility of sensor conformational changes in response
to alterations in cAMP levels (within several seconds) make
GloSensor probes excellent tools for direct tracing of real-time
cAMP dynamics in living systems.
Encoded by a single plasmid, GloSensor probes avoid
difficulties related to non-equality of expression of different
domains making a functional sensor, that are inherent to, e.g.,
CNGCs and multimolecular FRET probes, and can be used
in a variety of cell types and in principle should be applicable
to laboratory animals. Importantly, due to simplicity of signal
capture, attainable by a plain luminometer or luminescent
platereader, and ease of data analysis, the probes are quite user-
friendly. Most of the above features render GloSensor proteins
readily suitable for high-throughput tasks, e.g., massive library
screens of putative GPCRs interacting compounds (Pantel et al.,
2011).
At the same time, the luminescent signal from GloSensor
probes is not easily convertible to absolute cAMP values. In
principle, the sensors can be calibrated against any end-point
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assay measuring cAMP levels in cell lysates. Calibration of
this kind, however, is not quite straightforward and reliable,
as the intensity of luminescence in living cells transfected with
GloSensor probes appears to be affected by several factors,
including temperature, availability of the substrate and sensor
protein expression levels, which might not be easy to account
for (Binkowski et al., 2011b). Due to limited spatial resolution
GloSensor probes are mainly suited for measurements of cAMP
in cell populations rather than in single cells. Though GloSensor
proteins technically may be targetable to certain subcellular
compartments by fusion with localization signals, no reports
on generation of that kind of modified sensors have been
published so far. Altogether, when studies of intracellular
cAMP spatial organization are in question, biosensors with
higher spatial resolution, e.g., FRET-based probes, offer a better
solution.
Of note, GloSensor proteins have been harnessed for indirect
measurements of cAMP in non-transfected primary cell cultures
by means of co-incubation of primary cells (donor cells) with a
cell line stably transfected with GloSensor probe (sensor cell line),
in an assay called CANDLES (cyclic AMP iNdirect Detection
by Light Emission from Sensor cells; Trehan et al., 2014). This
coculture set-up allowed for bi-directional transport of cAMP
molecules via gap junction channels formed by neighboring
cells. In such fashion, a rise in cAMP concentration in donor
cells, triggered upon activation of GPCRs expressed exclusively
in these cells and not in the sensor cells, could be registered
in a kinetic fashion by a luminescent signal from the sensor
cells.
Although the authors showed the interspecies detection of
cAMP by this method, this assay might not be applicable to all
cell types, even from the same organism, as some cells might be
reluctant to form gap junctions with sensor cells, thus rendering
intercellular flow of cAMP impossible. Another drawback of this
method lies in its dependence on PDE inhibitors [such as 3-
isobutyl-1-methylxanthine (IBMX)] to inhibit cAMP degradation
(Trehan et al., 2014). Inability to register significant flow of cAMP
molecules between the cells once cAMP breakdown machinery
was fully active and not silenced with IBMX limits the resolution
of the method, as the readout captured in the absence of PDE
activity reflects severely distorted patterns of cAMP kinetics and
intracellular distribution.
Apart from this, it should be recognized, that the above
coculture set-up allowing for cAMP studies in primary cultures in
principle might be implemented with any other modern indicator
for cAMP expressed in sensor cells, e.g., with Epac and PKA-based
FRET probes, as was successfully demonstrated by Ponsioen et al.
(2007).
Lastly, when planning experiments with luminescent-based
enzymes, do not forget to account for one additional universal
drawback of this methodology—its dependence on a substrate
for the luciferase. This not only increases the expenditure on
the assay, but may also affect the resulting readout, as the
concentration and availability of the substrate are important
factors for signal generation. Moreover, some substrates are short
living, affected by pH and temperature, and hence limiting the
assay’s capabilities and usability.
cAMP Sensors, Based on
Conformation-Sensitive Fluorophores
The story of conformation-sensitive fluorophores starts from
the pioneering work of Tsien and colleagues, that culminated
in development of a novel class if Ca2+-biosensors, coined
“camgaroos” (Baird et al., 1999). Subsequently, the main principle
exploited in camgaroos was tailored to other applications,
providing the research community with a handful of robust
genetically-encoded indicators for various intracellular targets in
living cells, including Ca2+, cGMP, and some kinases (Whitaker,
2012; Gorshkov and Zhang, 2014).
In essence, the indicators from this family rely on
different circularly permutated variants of enhanced GFP,
which fluorescent properties are conformation-dependent. A
prototypical conformation-sensitive indicator consists of two
principal domains, a sensor and a fluorescent reporter, that
are fused together. A sensor domain is designed to bind a
desired target [e.g., calmodulin (CaM) for Ca2+ cations], and the
binding event is ultimately relayed into a conformational change
of a reporter protein, leading to a change in its fluorescence.
Though the readout is typically expressed as a ratio of two
emissions intensities (i.e., registered in basal and stimulated states
of a sensor), its fundamentally different from FRET, as all the
fluorescence is coming from a single fluorophore.
Despite the appealing design principle, no conformation-
sensitive non-FRET sensors for direct probing of cAMP have been
developed so far. Bonnot et al. (2014) reported the generation
of single fluorophore sensor for PKA activity in living cells, that
represents a modification of the original AKAR2 FRET biosensor
(see also the section of this review on FRET-based probes).
Conformation-sensitive mutant of GFP in this probe responds
to phosphorylation of the attached PKA substrate by a change
in fluorescence intensity and lifetime. Though this genetically
encoded indicator may be used for indirect probing of cAMP
levels, it is obviously inferior to direct sensors for cAMP and
should be reserved for the original application—studies of PKA
activity.
Another related methodology based on conformation sensitive
fluorophores that is applicable for cAMP measurements in living
systems have been recently published (Ding et al., 2015). The
assay general principle is based on heterologous co-expression
of a trio of interacting proteins in a single cell. While two of
the proteins carry fluorophores with different excitation/emission
spectra, the third member of the trio lacks any fluorescent
properties, but is able to dimerize with either fluorophores, acting
as their allosteric regulator. In monomeric (or unbound) state,
the fluorescent proteins are quenched and unresponsive to light
stimulation, but dimerization with the allosteric regulator triggers
conformational rearrangement of the pair, leading to dramatic
rise in fluorescence. Provided that the rate and preferential
direction of dimerization events between the regulator and the
fluorophore-carrying proteins are governed by defined stimuli
(e.g., intracellular calcium levels or certain enzymatic activity),
that can be achieved by fusion monomeric proteins with various
functional domains or bridging them with recognition sequences
for desired enzymes, this trio of proteins make an extremely
versatile platform, that have already been successfully used for
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probing of cAMP, calcium–calmodulin interactions, caspase-3
and extracellular signal-regulated kinase activity (Ding et al.,
2015).
For intracellular cAMP measurements in living cells, one of
the fluorophores (red) and the regulatory protein were fused
with the C subunit and R subunit of PKA, respectively, while
the second fluorescent protein (green) was designed to remain
in the cytoplasm in unbound state. This way, upon basal cAMP
levels the red fluorophore and the regulatory subunit remain
in close proximity, leading to strong emission of red light
against the faint emission of green light from the quenched
unbound second fluorophore. A rise in intracellular cAMP leads
to PKA holoenzyme dissociation and liberation of the regulatory
protein-R subunit chimera into cytoplasm, allowing it to bind
the second fluorophore with resulting increase in the green-
to-red emission ratio. As both fluorophores respond to cAMP
in antipodal directions, it improves sensitivity of the assay,
allowing for recognition of low-amplitude changes in cAMP
concentration. However, due to the necessity of cotransfection
with a set of vectors and inevitable differences in expression levels
of the regulator and the fluorescent proteins, the assay provides
qualitative rather than quantitative readouts. Measurements of
absolute values of cAMP are further hindered by different
binding affinities of the regulatory protein for its fluorescent
counterparts.
To summarize, genetically encoded sensors for cAMP based
on conformation-sensitive fluorophores make a new class of
tools, which holds good promise for the future. These sensors
are principally targetable to discrete subcellular compartments
by fusion with relevant localization signals and thus might be
used to gain insightful data on spatial organization of cAMP
signaling. Simplified readout and data analysis (in comparison to
FRET) makes conformation-sensitive probes more user-friendly
and brings them closer to HTS. However, issues with calibration,
absence of comprehensive data on kinetics of conformational
alterations, narrow signal-to-noise ratio and vulnerability to pH
changes leave some space for improvement and we are to await till
this sensor class has found its niche in cAMP research field.
Tools for Indirect cAMP Measurement in
Living Systems
As was previously mentioned, indirect probes are originally
designed to measure cAMP downstream effects rather than its
absolute concentrations. Therefore, though one can get a good
idea of cAMP levels with selected indirect probes, these tools
are generally inferior to direct sensors in this regard. But if used
wisely, indirect probes can provide a wealth of information on
cAMP signaling outcomes and hence remain actively involved in
cyclic nucleotide studies (Hill et al., 2010).
Probes, Based on CNGCs
Cyclic nucleotide-gated channels comprise a big family of
structurally related membranous ion channels, which are
activated by cGMP and cAMP. Upon binding with the above
cognate ligands, CNGCs undergo conformational change and
becomepermeable forNa+, K+, andCa2+, allowing these cations to
enter cytoplasm, which ultimately leads to either a depolarization
or a hyperpolarization event. In such fashion, CNGCs basically
function as switches that sense changes in intracellular cyclic
nucleotide levels and transform them into a change of membrane
potential and Ca2+ concentration. Originally discovered in retinal
photoreceptor and olfactory neurons, CNGCs have a pivotal role
in signal transduction of vision andolfaction. Besides this, CNGCs
have been shown to be of importance in functional regulation of
several other cell types and organs, including kidney, sperm cells,
endocrine tissues and pacemaker cells of the heart (Kaupp and
Seifert, 2002; Craven and Zagotta, 2006; Biel and Michalakis,
2009).
Though CNGCs and related hyperpolarization-activated cyclic
nucleotide-gated channels (HCNs) share the common CNBD
and bear general structure similarity, they operate in somewhat
different mode: CNGCs are solely cyclic nucleotide-dependent
and become permeable for Na+, K+, and Ca2+ upon activation,
while HCNs are mainly governed by voltage with cGMP and
cAMP acting only as fine regulators that adjust activation
threshold (activation voltage and activation time). In active state,
HCNs preferentially allow entry of Na+ and K+ but provide
very limited access to calcium ions (Kaupp and Seifert, 2002;
Biel and Michalakis, 2009; Akimoto et al., 2014). Of importance,
prolonged exposure to cyclic nucleotides does not lead to CNGCs
desensitization (Dhallan et al., 1990).
In such a way, a change in transmembrane electric current
and/or intracellular Ca2+ levels in CNGCs harboring cells
in principle may be used as an indirect measure of cAMP
oscillations. However, naturally occurring CNGCs are poor
sensors for cAMP due to several reasons: The major limitation
of wild-type CNGCs lies in their low responsiveness to cAMP
and preferential avidity for cGMP (Rich et al., 2001; Kaupp
and Seifert, 2002). Secondly, CNGCs activation threshold and
sensitivity to cyclic nucleotides are under negative feedback
control of calcium–calmodulin complex (Ca2+-CaM), which not
only narrows the dynamic range of wild-type CNGCs-based
assays, but brings possibility of interference with other signaling
events, that affect intracellular Ca2+ levels (Liu et al., 1994;
Trudeau and Zagotta, 2003). Another possible limitation to keep
in mind is that wild-type CNGCs may be directly activated by
nitric oxide (NO; Broillet, 2000).
In order to make CNGCs usable as cAMP sensors, a set of
genetically modified CNGC subunits has been generated and
tested in heterologous expression systems. Several combinations
of different mutant subunits were shown to form functional
CNGCs with desired properties, including higher affinity to
cAMP and decreased cGMP responsiveness, loss of negative
regulation by Ca2+-CaM due to alteration of CaM binding site
and inability to respond to NO. These genetically engineered
variants of CNGCsmade the platform for cAMPmeasurements in
a majority of successive studies (Altenhofen et al., 1991; Liu et al.,
1994; Varnum et al., 1995; Rich et al., 2001; Reinscheid et al., 2003;
Wunder et al., 2008).
Intracellular cyclic nucleotide levels in living cells were
measured with CNGCs for the very first time by Trivedi and
Kramer (1998), who used a change in membrane potential
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registered by a keen technique named patch-cramming for real-
time probing of cytoplasmic cGMP levels in single living cells.
Patch cramming involves heterologous expression of appropriate
sensor channels in donor cells (chimeric CNGCs consisting of
a—subunits from bovine rod and rat olfactory receptors were
expressed in Xenopus oocytes in the above study), removal of
a piece of cell membrane carrying CNGC and its calibration
with different concentrations of cGMP via inside-out excised
patch, with subsequent insertion (cramming) of the calibrated
membrane into a recipient cell so the inside part of the sensor
membrane is in direct contact with the cytoplasm of a recipient
cell. This way, the sensor membrane on a tip of a pipette responds
to changes in cytoplasmic cGMP levels of recipient cell by
activation of CNGCs, leading to alterations in electric current that
can be readily registered with patch clamp. The “patch cramming”
approach allowed Trivedi and Kramer (1998) to follow cGMP
levels in living neuroblastoma cells and rat neurons in real-time
fashion, providing kinetic readout of cGMP oscillations scarcely
attainable before. However, this methodology was obviously quite
labor-intensive, involved multiple technically demanding steps
and was applicable only to relatively large cells with a diameter
of about 40 mm and higher.
A refinement followed a few years later—by means of viral
transduction heterologous CNGCs and HCNs were directly
expressed in the cells of interest and cytoplasmic cAMP
fluctuations upon exposure to different stimuli were registered
in single living cells in real time by means of whole-cell, inside-
out, and perforated patch clamp (Rich et al., 2000, 2001; Heine
et al., 2002). Thus, the limitations of the cell size and the need
of harvesting a piece of CNGCs-carrying sensor membrane from
donor cells were eliminated, facilitating more rapid and flexible
assay flow.
Despite the above advances, CNGC-mediated measurements
of cAMP were still invariably based on registration of electric
currents by patch-clamp, which restricted the processivity of the
method (one measurement—one cell) and required sophisticated
probing tools and a skillful operator. The above limitations have
been partially circumvented in the recent decade via development
of automated patch-clamp instruments, though these tools are not
readily available tomajority of laboratories and remain to be tested
for most of the cell types (Farre and Fertig, 2012).
Another general shortcoming of patch-clamp technique
(excluding whole-cell setup) is that it can probe electric currents
only in the immediate vicinity of a patch pipette tip, which
restricts the measurements of cAMP to cell compartments that
can be patched. For CNGCs, which expression is confined to
plasma membrane, it means that patch-clamp allows to probe
cAMP changes occurring exclusively in submembranous regions,
providing little information on the events in other cellular
compartments (Rich et al., 2000, 2014).
The aforementioned drawbacks can be bypassed by harnessing
Ca2+ cytoplasmic oscillations as a measure of cAMP-driven
CNGCs activation. Various methods for Ca2+ probing have
been successfully applied to this aim, but most frequently
Ca2+-sensitive cell permeant dyes such as fura-2/AM, indo-
1/AM and fluo-3 AM/fluo-4 AM have been used (Grynkiewicz
et al., 1985; Fagan et al., 2001; Rich et al., 2001; Visegrády
et al., 2007). These established Ca2+ indicators provide either
direct (increase in fluorescence quantum yield upon Ca2+
binding—fluo-3 and -4 dyes) or ratiometric (fura-2 and indo-
1 dyes) measure of intracellular Ca2+ levels. Though both
types of dyes are quite sensitive and easy to use, ratiometric
indicators appear to be advantageous, as readout expressed as an
emission/excitation wavelength shift allows to avoid unwanted
effects of uneven loading, photobleaching and noise from non-
specific autofluorescence, thus yielding higher signal-to-noise
ratio and less variability.
Besides imaging of CNGCs-mediated Ca2+ surges in
cytoplasm of a single cell with standard fluorescent microscopy,
fluorescent Ca2+ dyes are readily applicable for measurements
in cell populations, i.e., with the help of a multiwell
platereader/spectrofluorometer equipped with appropriate filter
sets, thus rendering this assay principle readily suitable for HTS
(Reinscheid et al., 2003; Visegrády et al., 2007).
Apart from Ca2+-sensitive dyes, another approach initially
developed for Ca2+ probing in living cells have been subsequently
harnessed for cAMP measurements. Oscillations of intracellular
Ca2+ triggered by cAMP-dependent activation of CNGCs can be
registered with aequorin-based sensors (Sheu et al., 1993;Wunder
et al., 2008; Richter et al., 2015). Consisting of two subunits,
the apoprotein apoaequorin and its cofactor coelenterazine,
aequorin is a well-studied bioluminescent protein from the
jellyfish Aequorea victoria. Binding of free Ca2+ Ca2+ to aequorin
triggers oxidation of coelenteramide, leading to generation of
light and the holoprotein complex dissociation. The amount
of photons emitted is proportional to Ca2+ ions concentration
and can be easily registered with either a charge-coupled device
(CCD) camera or a luminometer (Shimomura, 1985). In such
fashion, successful co-expression of CNGCs and apoaequorin
allows to measure cAMP in virtually any cell type. Besides, this
methodology is not technically demanding and HTS-friendly
(Wunder et al., 2008).
However, the generation of cell lines stably transfected with
CNGCs and apoaequorin is quite time-consuming and might
happen to be problematic, especially if one does not have all
the components making the functional system in a single vector.
Another limitation of this type of assay is the need of spiking
the cells with Ca2+ in order to trigger aequorin break-up and
light emission. This, together with short-lasting nature of Ca2++
responses (.30 s), limits the processivity of the method. At the
same time, the latter issue might be bypassed by running the assay
in a multiwell format (e.g., 96- or 384-well plates) on a platereader
that is equipped with liquid dispensing system.
Apart from the Ca2+-sensitive fluorescent dyes and
apoaequorin-based assays, past decades witnessed the generation
of another type of Ca2+ sensors, that have literally changed
the field of calcium signaling research—this entails the class of
genetically-engineered fluorescent proteins, capable of measuring
Ca2+ oscillations bymeans of change in FRET intensity (Miyawaki
et al., 1999; Whitaker, 2012). Though FRET sensors can
provide excellent spatial resolution down to subcellular domains
(discussed earlier) and obviously have a great potential for studies
of crosstalk between cAMP andCa2+ signaling, they have not been
widely used in conjunction with CNGC.
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Yet another quite similar approach for indirect intracellular
cAMP measurement in living cells is based on membrane
potential sensitive dyes such as DiSBAC2(3) and HLB 021-152.
These molecules are impermeable to cells until plasmamembrane
depolarization occurs; once in the cytoplasm they exhibit a
dramatic rise in fluorescence after binding with intracellular
solutes and proteins, which can be registered with a conventional
spectrofluorimeter or fluorescent microscopy. This assay format
has been optimized for HTS as well (Tang et al., 2006; Visegrády
et al., 2007).
To conclude, genetically-engineered CNGCs with increased
sensitivity to cAMP represent a versatile analytical tool that can be
tailored to wide array of research needs (Figure 2). Measurements
of inward currents and membrane potential with patch-clamp
allow one to have all the advantages that the very nature of CNGCs
provides, including high spatial resolution, snap-shot responses to
change in cyclic nucleotide levels within dozens of milliseconds,
lack of saturation, excellent sensitivity and fair dynamic range,
possibility to obtain absolute values of cAMP levels by means
of excised patch calibration. However, these benefits are only
available to dedicated and well-equipped labs with a strong record
in electrophysiology and typically come at the expense of low
processivity.
Ca2+-sensitive dyes and apoaequorin-based sensors are easier
to use and suitable for HTS, although absolute levels of
intracellular cAMP usually remain elusive due to infeasibility
of calibration. Another shortcoming of using Ca2+ levels as a
measure of cAMP is the possible interference fromother pathways
involving Ca2+ signaling.
Necessity of CNGCs expression in heterologous systems
by means of transfection/transduction makes an inevitable
common limitation of CNGCs-based assays. This issue becomes
especially important once the different subunits comprising a
functional CNGC are delivered by separate vectors or another
exogenous genetically encoded sensor is used in conjunction (e.g.,
apoaequorin). Another thing to keep in mind is that high spatial
resolution of cAMP measurements in submembranous regions
achievable with CNGCs-based methods turns into a disadvantage
once cAMP dynamics in another cellular domains comes into
question, as membrane-anchored CNGCs can respond to cAMP
only in the immediate vicinity of thereof. Last, but not least,
despite rapid activation and kinetic-like pattern of signal, with
CNGCs one should not expect to obtain genuine kinetic data on
cAMP fluctuations over time, as themeasurable response to cyclic
nucleotides is indirect in essence and mediated by either inward
ionic currents or Ca2+ levels. In inherently complex living systems
there is virtually no place for strictly linear relations between any
two given cross-talking pathways—and each of these has its own
mode of signal transduction and tends to be intertangled with
a number of third parties. Ca2+ signaling and transmembrane
electric currents do not make an exception from the above.
Reporter Gene-Based Systems
Reporter gene-based systems perhaps make the most illustrative
example of indirect assay for cAMP, as these tools score on
one of the most remote effects of cAMP, i.e., its effect on
transcriptional activity. A rise in intracellular cAMP triggered
by a variety of stimuli (most frequently, due to activation of
ACs via Gas—coupled GPCRs) leads to dissociation of PKA with
successive entry of liberated C subunits into cell nucleus and
the phosphorylation of cAMP-response element (CRE)-binding
proteins (CREBs). Phosphorylated CREBs then bind to CRE
elements within promoter regions of a multitude of genes, thus
altering their transcription (Neves et al., 2002; Wettschureck and
Offermanns, 2005; Musnier et al., 2010). In such way, a change
in protein levels may be used as indirect measure of cAMP
oscillations.
CRE consensus sequence (TGACGTCA) and its variations
might be found in promoter regions of thousands of genes across
human genome (Lalli and Sassone-Corsi, 1994; Zhang et al.,
2005). However endogenous promoters have not been frequently
used for cAMP studies, as they tend to encompass binding
sites for other transcriptional factors as well, thus rendering
reporter protein synthesis not solely cAMP-dependent (Hill et al.,
2001). Genetically-engineered promoters harboring only CRE
elements do not have this limitation and thus provide a viable
alternative. Along with this, synthetic promoters are not totally
problem-free and require thorough validation in order to yield the
best transcriptional response, including testing of different CRE
elements and various numbers of repetitiveCRE sequences, aswell
as the reporter gene (Dinger and Beck-Sickinger, 2002; Shan and
Storm, 2010; Hald et al., 2015).
The choice of reporter proteins is broad and the selected
reporter generally should be tailored to particular needs.
The possible options include different enzymes allowing for
absorbance (e.g., alkaline phosphatase and b-galactosidase) or
luminescence-based readout (different types of luciferases),
fluorescent proteins and combinations of thereof (Hill et al., 2001;
Jiang et al., 2008). If the assay in question is well-optimized and
sensitive enough, all of the above reporters are able to provide a
reasonable estimate of cAMP effects in living cells.
Despite relative ease of use, all reporter gene-based assays
share a number of limitations, which should be taken into
account already at the stage of experimental design. As all the
reporter-based assays are dwelling on the readout coming from
a protein product of a synthetic construct, this construct has to
be delivered to cell nucleus for successful expression by means
of transfection or viral-mediated transduction. Obviously, this
brings along all the possible issues with transfection/transduction,
including low success rates in certain cells types, significant
inter-run variation in terms of transfection efficacy, excessive
toxicity due to gene delivery procedure per se and poor
applicability of the method to in vivo settings (Kim and
Eberwine, 2010). However, as already discussed earlier, similar
problems are in essence inherent to all of the genetically-encoded
proteins and hence to the bulk of cAMP biosensors presently
available.
Some of the transfection-related difficulties like run-to-
run variation in reporter expression levels, leading to high
heterogeneity of response and/or poor signal-to-noise ratios, may
be circumvented by generation of stable cell lines with relatively
uniform and equal expression of reporter. Of note, this strategy,
although offering a good solution, is not flawless, as even with
stable clones, the number of transgene copies, the location of the
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FIGURE 2 | Harnessing CNGCc for indirect measurement of cAMP. (A) Basic operational principle of CNGCs: binding of cAMP (red triangle) to CNGCs results
in channel opening for cations, allowing Na+ and Ca2+ to enter the cytoplasm. (B) Changes of the membrane potential and transmembrane electric currents,
mediated by cAMP-driven CNGCs activation, can be registered with patch-clamp technique and serve as an indirect measure of cAMP levels. (C,D) Instruments,
initially designed to measure concentration of intracellular Ca2+, can be applied in combination with CNGCs for indirect sensing of cAMP. Inorganic dyes (e.g., fluo-3),
that demonstrate a pronounced rise in fluorescence upon binding of Ca2+ (C), and bioluminescent protein apoaequorin, responding to Ca2+ by generation of light
(D), have been successfully used to this end.
genomic loci of insertion and the state of the cells, e.g., passage
number, might introduce massive variability (Jonas et al., 2013).
The establishment of a stable line is a laborious process and
does imply extra requirements to reporter construct, as it should
confer antibiotic resistance for efficient selection of stable clones.
Besides, the reporter construct should ideally encode a fluorescent
tag allowing for negative selection of a fraction of stable clones
with highest basal levels of reporter expression, providing the
resulting cellular system with optimal sensitivity to cAMP (Hald
et al., 2015). On top of it, the above approach is essentially non-
applicable to primary cell cultures with a finite life span.
Another potential problem with reporter gene-based systems
is related to basal promoter activity in the absence of its
cognate transcription factor (CREB). This might happen when
the strong promoter is being used (e.g., cytomegalovirus or
phosphoglycerate kinase), thus leading to reporter protein
synthesis in response to basal cAMP levels, which undermines
assay performance and might lead to false-positives (Scarff et al.,
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2003; Hald et al., 2015). At the same time, this problem might be
minimized via promoter rejigging or via prior negative selection
of the cells exhibiting significant reporter signal in unstimulated
state, thus yielding a homogeneous basally silent population. The
latter strategy is feasible in cases when the reporter gene encodes
for either a fluorescent protein (Kotarsky et al., 2001; Hald et al.,
2015) or certain enzymes coupled to fluorescent readout (e.g.,
cleavage of FRET substrate CCF2/AM by reporter b-lactamase,
leading to drop in FRET efficiency, as reported by Zlokarnik et al.,
1998), thus allowing for facile removal of basally active cells via
fluorescent-activated cell sorting.
Excessive reporter protein stability presents yet another possible
limitation of reporter gene-based assays. Obviously, if a reporter
protein is quite stable and has a natural decay period of more
than several hours [which is the case with many conventional
fluorescent or enzymatic reporters (Van Diggelen et al., 1980;
Corish and Tyler-Smith, 1999)], this will have a huge impact on
an assay sensitivity and dynamic range, as first reporter molecules
that have been synthesized upon initial cAMP stimulationwill still
be present and actively signaling after several hours, thus adding to
any resulting readout from successive surges of cAMP (Hill et al.,
2001).
The above limitation might be partially circumvented by using
genetically-engineered reporters destined for fast proteolytic
degradation, as was successfully achieved by fusing PEST domain
of mouse ornithine decarboxylase or mouse cyclin B1 destruction
box to C- or N-termini of GFP, respectively, shortening GFP
half-life to 2–6 h (Li et al., 1998; Corish and Tyler-Smith, 1999).
Leclerc et al. (2000) applied similar strategy to a firefly luciferase,
engineering the mutant enzyme with a functional half-life of only
50 min (in contrast to 4 h of wild-type enzyme).
Another way to obtain data on cAMP-driven kinetics of gene
expression is to use a reporter that is released into cell medium,
e.g., secreted isoforms of placental alkaline-phosphatase or b-
lactamase (Cullen, 2000; Qureshi, 2007). By repeatedly removing
cell medium and analyzing multiple sequential samples, one
can minimize the effect of reporter protein accumulation and
increase the dynamic range of the assay. Although this multiple
sampling approach can convey some idea of intracellular cAMP
fluctuations and expression of cAMP-dependent genes over time,
it is still a way from deducing the genuine kinetics of cAMP-
driven transcription, which is attributed to inherent features of
signal transduction from the level of cAMP to CRE regions. As
was previously shown by Hagiwara et al. (1993) slow entry pace
of PKA catalytic units into cell nucleus, their low affinity for
CREB and low concentrations of the latter basically promote
a slow and relatively long-lasting transcriptional response with
early saturation of the downstream signal, which is in striking
contrast with seconds-lasting amplitude surges of cAMP within
cytoplasm.
The amplification of the downstream signals on the way
from the plasma membrane to the nucleus is a well-known
phenomenon (Wettschureck andOffermanns, 2005). Considering
this, the initial signal, encoded by a rise in cAMP upon GPCRs
activation, will be augmented manifoldly by the time it reaches
CRE loci of reporter genes in the nucleus. This general nature of
signal transduction might be advantageous if one is studying the
effects of low-amplitude oscillations of cAMP. However, in the
presence of pronounced changes of cAMP the above benefit turns
into a limitation, as the signal relay quickly gets saturated of on the
levels of nucleus entry and transcriptional regulation (discussed
above), narrowing the dynamic range of the assay and blunting its
ability to reflect actual magnitude of cAMP oscillations. Besides,
the phenomenon of signal amplification should be duly accounted
for when interpreting the data from reporter gene studies—the
importance of this in nicely exemplified by partial GPCR agonists,
which might appear to act as full agonists (Baker et al., 2003).
As reporter assays rely on the readout from the remote
point of cAMP signaling cascade, there is always a possibility
of interference with other signal transduction pathways. The
presence of such confounding input might significantly affect
the overall results of an assay, obscuring the actual changes of
cAMP in specimens under study (Hill et al., 2010). Besides,
as the way from cAMP to reporter protein encompasses
multiple steps, any compound or investigational molecule
to be used in the assay must not interfere with all the
components of normal cell machinery involved in protein
synthesis (i.e., transcription, translation, protein trafficking, and
post-translational modifications). In such a way, results of
essentially any reporter gene-based assay might warrant further
validation in at least one extra assay of different format, which is
not immediately dependent on protein synthesis.
Finally, when used separately, reporter gene assays are poorly
applicable for studies of cAMP spatial dynamics in various
subcellular compartments, as the readout from the assays
indirectly reflects only the net change in total pool of free cAMP.
Hence, a signal from a reporter protein usually confers little
information on the initial hot spots of cAMP generation and its
successive intracellular flow.
To conclude, reporter gene-based assays make a reasonable
choice once the transcriptional effects of cAMP are in the focus
of research interest. However, if one wants to have a closer look at
cAMP dynamics above the level of gene expression, e.g., patterns
of cAMP synthesis, diffusion and decay, biosensors for direct
cAMP probing clearly should be used instead.
Selection of the Right cAMP Sensor for
Experiment
Given the wide array of different biosensors for cAMP currently
available, selection of the right one for a given experiment
sometimes might present an uneasy task. Naturally, the choice of
a sensor is dependent on particular research objectives. Indeed,
if aiming at the levels of cAMP per se, direct sensors apparently
make the best choice, but once the effects of cAMP signaling,
such as transcriptional changes of cAMP-responsive genes, are in
question, appropriate indirect sensors should come into action.
Though the indirect sensors at large allow for the reverse scenario,
i.e., reporter gene-based systems or CNGCs may be applied
for measurements of cAMP oscillations, the limitations of such
approach and its general inferiority to direct biosensors used for
the same task should be duly recognized. Once the principle
research goals have been identified, additional requirements to
the readout (resolution to subcellular domains? HTS? Real-time
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cAMP kinetics?) should ultimately spotlight the most appropriate
biosensor for the particular experimental project.
Another issue worth considering is the expertise with desired
experimental techniques and availability of equipment, as
some biosensors require a skillful operator and a dedicated
set of tools for optimal performance (e.g., CNGCs-based
sensors coupled with patch-clamp or FRET probes applied to
gain subcellular resolution). Lastly, one should not disregard
conventional biochemical assays for cAMP, such as ELISA,
RIA, HTRF (homogeneous time resolved fluorescence) or
AlphaScreen. If no high spatial or temporal resolution is
required and the total cAMP levels in a sample at a single
time point is all that is needed, biochemical assays for cAMP
obviously are the easiest and highly reliable choice. These
established analytical tools offer ready-to-use solutions with
minimal requirements for optimization and are applicable to
vast array of cell types and tissues, providing robust data on total
cAMP levels in cellular populations (Williams, 2004; Hill et al.,
2010).
A decision diagram, which we hope will aid the reader in
cAMP biosensor selection, is presented in Figure 3. Universal
limitations, that are inherent to the bulk of the genetically encoded
probes irrespectively of the nature of signal they produce, are
summarized in Figure 4.
Cutting-Edge Genetically-Encoded Tools
for Modulation of cAMP in Living Systems
Apart from the biosensors reviewed earlier, recent progress
in synthetic biology endowed the research community with
principally novel and extremely powerful tools for modulation
of cAMP in living systems. Photoactivatable adenylyl cyclases
(PACs) and PDEs perhaps make the most remarkable example of
such achievements. These ingenious optogenetic enzymes allow
researchers to enjoy all the benefits of light as the steering wheel,
including exquisite spatio-temporal dosing of exposure, minimal
toxicity and negligible interferencewith physiological intercellular
processes. Naturally occurring photoactivatable proteins carry
light sensitive domains that translate the energy of absorbed
photons into conformational rearrangements of the whole
molecule. The change in protein structure triggered by light
typically affects protein functional state, e.g., leading to alteration
in its enzymatic activity (Karunarathne et al., 2014).
The first PAC was isolated from the unicellular flagellate
Euglena gracilis (Schröder-Lang et al., 2007). Each subunit of
this tetrameric EuPAC protein harbors a couple of photosensitive
BLUF domains (Blue Light receptor Using FAD) and has own AC
activity that is stimulated by blue light.
EuPAC showed excellent performance in heterologous
expression systems (HEK293 cells, Xenopus laevis oocytes and
central neural system of Drosophila melanogaster), with up to 10-
fold enhancement of cAMP production upon exposure to blue
light. AC activity of EuPAC was clearly dependent on magnitude
of stimulation (both light intensity and duration of exposure)
and exhibited an ultra fast on-off response within dozens
of milliseconds. However, despite the remarkable functional
features, EuPAC has not been widely used in successive studies,
mainly due to significant dark activity and big molecular weight
precluding efficient and problem-free expression.
Another PAC, discovered a few years thereafter in soil bacteria
Beggiatoa sp. (hence the name—bPAC), did not suffer from the
above limitations of EuPAC and made an extremely valuable
addition to the cAMP researchers toolbox (Ryu et al., 2010; Stierl
et al., 2011). This small BLUF domain-containing enzyme (350
amino acids, that is roughly one-third of the size of EuPAC) has
negligible activity in the dark, which is inducible up to 300-fold
upon exposure to blue light. Besides, in comparison to EuPAC
this native bacterial photoenzyme requires much less irradiation
to generate comparable concentrations of cAMP and preserves
light-induced active conformation for longer time, thus providing
more durable response. Blue light stimulates enzymatic activity
of yet another PAC, identified in cyanobacterium Microcoleus
chthonoplastes (Raffelberg et al., 2013). In contrast to the BLUF
PACs discussed above, this enzyme, coined mPAC, has a LOV
(Light, Oxygen, Voltage) domain for light-sensitive unit, but
otherwise operates in the similar fashion.
Despite successful use of blue-light sensitive PACs in vitro and
in selected small animal models (i.e., Drosophila), the general
application of these tools to in vivo setting is hindered by low
tissue penetration depth of blue light (Wan et al., 1981). PACs,
activatable by near-infrared light, which can pass in bodily tissues
as far as several centimeters, provide an excellent alternative.
The first PAC of this kind was engineered by Ryu et al. (2014),
who fused together a light-sensitive domain of phytochrome
from Rhodobacter sphaeroides and AC from bacterium Nostoc sp.
The resulting chimeric enzyme was efficiently regulated by red
light, including in vivo, as was demonstrated by an alteration
of locomotory activity in Caenorhabditis elegans, expressing this
PAC in cholinergic neurons.
On the opposite end of cAMP regulation, a light-activatable
phosphodiesterase (LAPD), recently introduced by Gasser
et al. (2014), represents a fine-tunable instrument for cAMP
degradation. A chimera protein of photosensitive phytochrome
from Deinococcus radiodurans and human PDE2A, LAPD is an
extremely versatile optogenetic enzyme, as it responds to both blue
and red light with an increase of PDE activity reaching sixfold, and
is down-regulated by far-red light. LAPD was already successfully
tested in cell cultures and zebrafish embryos, and will probably
soon be applied in larger animal models (Gasser et al., 2014).
To conclude, ACs and PDEs engineered as optogenetic tools
open breath-taking avenues for cyclic nucleotide research. As
genetically-encoded single chain proteins, these photoactivatable
enzymes are proven to be applicable to majority of modern model
systems, including in vivo setting. Secondly and luckily enough,
the indispensable cofactors for all of the discussed optogenetic
proteins, that are required for efficient sensing of photon energy
and its relay to conformational changes, are naturally present
in sufficient quantitates in most types of living cells and tissues
(i.e., biliverdin chromophore for LAPD and red light-dependent
PACs, flavins for BLUF and LOV-harboring PACs), thus obviating
the need for their exogenous supply. In such a way, all that
is needed for triggering the desired activity (AC or PDE) in a
biological sample under study—is to illuminate it with the light
of appropriate wavelength and intensity. With spatial resolution
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FIGURE 3 | Selection of the task-specific biosensor for cAMP probing in living cells—a decision tree.
FIGURE 4 | Universal limitations inherent to most genetically encoded biosensors for cAMP.
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defined by the width of the light beam and ultra-flexible timing
of stimulation, optogenetics enzymes are a way ahead of the
pharmacological agents traditionally used in cAMP research,
such as non-specific AC stimulator forskolin (FSK) and PDE
inhibitor IBMX. The engineering of PACs and PDE activated
by red and near-infrared light paves the way for non-invasive
modulation of cAMP in living animals, allowing to study and
fine-tune cyclic nucleotide signaling in otherwise non-disturbed
tissue microenvironment. Moreover, one can readily envision
the combined used of photoactivatable ACs and PDEs in a
single cellular system or animal model for a full cycle cAMP
control, provided that both enzymes have well-separated spectral
characteristics.
Apart from the photoactivatable proteins, we would like to
highlight another pair of genetically-encoded tools that may be
fruitfully employed in living systems for cAMP modulation. The
first instrument is based on a modified soluble AC (sAC), a
special isoform of AC that is directly regulated by bicarbonate
ions (HCO3 ) and involved in pH sensing in a variety of tissues
(Rahman et al., 2013). By decorating truncated catalytically active
rat sAC with the appropriate localization signals, Sample et al.
(2012) were able to express sAC constructs in desired domains
of living cells. Stimulation of the cells with bicarbonate readily
triggered fast and sustained activation of sAC leading to rise
in cAMP in the subcellular compartments sAC was targeted to.
Moreover, sAC activity was proportional to the concentration
of bicarbonate anions and quickly returned to basal state after
bicarbonate removal. Therefore, the engineered sACs provide
quite precise and versatile means of chemical control of cAMP
production, making a nice addition to PACs.
The second instrument, named cAMP sponge, represents a
truncated variant of the RIb regulatory subunit of PKA, which
preserves high affinity for cAMP, but cannot dimerize or bind
PKA catalytic subunits (Lefkimmiatis et al., 2009). In such way,
sponges are designed to act as scavengers of cAMP molecules that
limit availability of free cAMP to its effectors, but do not interfere
with cAMP generation or degradation. Sponge proteins can also
be routed to certain subcellular compartment (cell membrane,
cytoplasm, or cell nucleus) by means of addition of appropriate
localization signals and were shown to blunt cAMP oscillations
triggered by either GPCRs activation or FSK. Besides, cAMP-
sponges successfully attenuated PKA activity, measured in living
cells by AKAR sensors. These features make sponges potentially
useful tools for complex experimental perturbations of cAMP
signaling in different microdomains of living cells.
All in all, modern genetically encoded proteins for cAMP
modulation provide hitherto unattainable opportunities for
experimental interference and modeling of such major aspects of
cAMP life cycle as cAMP generation, trafficking and hydrolysis.
The genuine power of these tools obviously dwells in synergy
with biosensors for cAMP. Flexibility of design and targetability
to desired subcellular compartments, inherent to both modern
probes and instruments for cAMP modulation, combined with
excellent spatiotemporal resolution of selected biosensors, in
principle allow for real-time studies of precisely induced cAMP
waves across several domains of a single living cell. Apart from
this, introduction of a second opinion (e.g., FRET bioprobes
for Ca2+) shall expand research potential of a living system
even further, opening avenues for insightful studies of cAMP
interaction with other intracellular players. Recent results,
obtained with the help of combinatorial applications involving
several distinct genetically-encoded proteins, support the bright
perspectives of this methodology—that is coming of age and
shaping the vectors of future research endeavors (Sample et al.,
2012; Tsvetanova and von Zastrow, 2014).
Currently, genetically-encoded tools for cAMP fuel the
transitional phase of the whole filed of cyclic nucleotide
research, shifting the focus from the unresolved and single
time point measurements in cellular populations toward the
pinpoint real-time modulation and probing of cAMP in discrete
subcellular domains of a given cell. And with the present pace of
biotechnology the newer and even more advanced instruments
are quite likely to come, giving us the possibility to challenge
established ideas and pursuit even bolder hypotheses.
A Perfect Sensor for cAMP in Living
Systems—Prospects for the Future
If we could think of a perfect sensor for cAMP, what principle
features should it have? Firstly, and in contrast to all of
the biosensors discussed in this review, a perfect sensor
should be totally independent of physiological/pathophysiological
processes, occurring in a living system, including transcription,
translation and post-translational modifications. Obviously, in
order tomake this possible, a sensor has to be delivered to a system
in a ready-to-use state, thus obviating the need of conversion of a
gene template into a functional sensor protein by recipient cell’s
protein synthesis machinery, which is the case with all genetically-
encoded sensors for cAMP presently available. Only then it would
be possible for a sensor to produce the most objective readout
of cAMP dynamics in living cells or tissues under virtually any
possible condition, including such extremes as pronounced stress
or advancing cell death. In such fashion, a sensor that is based on a
biological cAMP—responsive domain, might still be considered a
genetically-encoded tool, but transcription and translation events
from a coding sequence should happen in a dedicated expression
system (e.g., bacteria, plant cells, or yeast) and not in the living
system to be analyzed.
Secondly, a perfect sensor should be easy to deliver to living
cells, with the procedure of delivery per se affecting cellular
well-being as minimally as possible. This will also facilitate the
measurements of cAMP levels in delicate primary cells or even
tissues (in vivo). Targetability of a sensor to selected intracellular
compartments, such as nucleus and mitochondria, would be
highly desirable as well. Lastly, an ideal sensor designed for
measurement of absolute values of cAMP should directly bind
and sense cAMPmolecules, with binding event being immediately
coupled to signal generation and rapidly reversible, producing
flash ON–OFF responses and minimizing cAMP buffering. Apart
from the favorable kinetics of response to cAMP, allowing
for real-time measurements, the signal from a sensor should
be reasonably strong, providing sufficient spatial resolution for
studies of cAMP oscillations in subcellular domains of single
living cells.
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For the time being, we could not think of any possible
unimolecular sensor meeting the above criteria. The solutions
might possibly lie in the interface of synthetic biology and
nanotechnology, culminating in engineering of such smart
devices, as nanoparticulate carriers equipped with cAMP-sensing
elements. Nanocarriers already hold a strong position in the field
of drug delivery and might make an excellent vehicle for cAMP
sensors. A huge variety of different platforms, from liposomes and
nanorods to silica- or metal-based nanoparticles, offers immense
design flexibility—bymeans of decorationwith various functional
elements (antibodies, ligands to endogenous receptors expressed
in particular cell types, smart bioshells, degradable by selected
enzymes or in response to pH change), nanocarriers can be
conceptually engineered for highly selective transportation of
cAMP sensors to desired cellular population or tissue types in
living multicellular organisms, let alone cell lines or primary
cultures in vitro (Sahay et al., 2010; Sikorski et al., 2015). With
the current advances in the nanoscience, we are fully justified to
expect development of dedicated nanocarriers for cAMP sensor
delivery in the nearest future. Of note, alternative solutions for
a delivery of ready-to-use cAMP sensors might well arrive from
a different direction—for instance, one could envision that a
biosensor could be delivered ready-to-use by means of one of
the protein transduction domains, also called cell-penetrating
peptides, such as TAT, PEP-1, Antennapedia, or Arg-9 (Heitz
et al., 2009). The delivery of sensors by such peptides could be
coupled with a protein localization signal and even a switch that
becomes activated only in specific cell compartments and/or cell
types. This approach, to the best of our knowledge, has not been
yet explored.
As for the principal component of any cAMP sensor, that is a
unit responsible for binding of cAMP molecules and relaying the
binding events into a traceable signal, we envision that the future
generations of these elements will primarily stem from cAMP
binding molecules originally evolved in nature and subsequently
modified for the purpose, just like as already happened to all
genetically-encoded cAMP sensors engineered so far. However,
apart from the established biological cAMP effectors, such as
PKA, Epac proteins and CNGCs, new scaffolds for cAMP sensor
elements are likely to emerge, with ribozymes (RNA molecules
with enzymatic activity) being a good and promising example
(Koizumi et al., 1999). Combinatorial use of the above natural
cAMP effectors with purely synthetic tools, e.g., cAMP-avid
RNA aptamers, might lead to the creation of principally new
classes of cAMP sensors with improved capabilities (Koizumi and
Breaker, 2000; Paige et al., 2012; Kellenberger et al., 2013). Finally,
further studies in the fundamental principles of cAMP signaling
organization might well uncover hitherto unrecognized cAMP
counterparts, opening new horizons for cAMP biosensors design.
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